Dapagliflozin + Metformin + Vildagliptin is mainly used to manage type 2 diabetes mellitus. It belongs to the group of sodium-glucose co-transporter 2 (SGLT2) inhibitors, biguanides, and dipeptidyl peptidase-4 (DPP-4) inhibitors
Nausea
Back pain
Upper respiratory tract infection
Diarrhoea
Dapagliflozin belongs to a category called sodium-glucose co-transporter 2 (SGLT2) inhibitors. In simple terms, it blocks the action of a protein in the kidneys which reabsorbs sugar back into the blood. By doing so, it helps to eliminate more sugar from the body through urine, thereby reducing the overall blood sugar levels.
Metformin is a biguanide. It operates by decreasing the amount of sugar produced by the liver and absorbed by the intestines. It also improves insulin sensitivity, which means that body cells are better able to take up and use sugar, further aiding in lowering blood sugar levels.
Vildagliptin, is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by slowing down the breakdown of insulin-producing hormones in the body. As a result, your body produces more insulin when needed and reduces the amount of sugar made by your liver when it is not needed. This keeps blood sugar levels under control.
MSc (Applied Genetics)
BAMS, APG, PG
The combination of Dapagliflozin + Metformin + Vildagliptin can be taken orally (tablet).
This medication is intended for use in adults.
Dapagliflozin + Metformin + Vildagliptin is contraindicated in patients with severe renal impairment, end-stage renal disease, patients on dialysis, and acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. This medication should not be used by individuals who have had a serious hypersensitivity reaction to vildagliptin, such as anaphylaxis or angioedema.
Dapagliflozin + Metformin + Vildagliptin combination may interact with carbonic anhydrase inhibitors (e.g., acetazolamide), loop diuretics (e.g., furosemide), medicines that reduce metformin clearance (e.g., ranolazine, vandetanib), and insulin secretagogues (e.g., sulfonylureas).
An overdose of the combination medicine may cause dizziness, electrolyte imbalances, lactic acidosis (symptoms include rapid breathing, muscle pain, unusual tiredness, or stomach discomfort) and low blood sugar. Consult your doctor immediately as clinical monitoring and supportive treatment may be necessary depending on the patient's clinical status.
If a dose is missed, take it as soon as you remember. However, if it is near the time for the next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
To manage frequent urination or increased thirst caused by dapagliflozin, try drinking plenty of water throughout the day.
To manage gastrointestinal side effects caused by metformin such as diarrhoea or nausea, take this medicine with a meal.
Dapagliflozin + Metformin + Vildagliptin may cause side effects like dizziness, light-headedness or tiredness. If you experience these, avoid driving or operating heavy machinery.
This medication should be used during pregnancy or lactation only if the potential benefit justifies the potential risk to the fetus or infant. It is important to consult your doctor before taking this medication during pregnancy or while breastfeeding.
This medication should be used with caution in patients with liver impairment, as metformin dosage may require adjustment for these patients.
Regular monitoring of blood glucose levels is recommended to ensure the medication is working effectively.
Be cautious with carbohydrate-rich foods, as they can affect blood glucose levels.
Increase water consumption to support the action of Dapagliflozin, which works by increasing glucose excretion in urine, and to prevent dehydration.
Frequently asked questions
No, Dapagliflozin + Metformin + Vildagliptin is not known to cause weight gain. If you have any concerns about your weight changes, consult your doctor.
No, you should not stop taking this medicine without consulting your doctor. Abrupt discontinuation might lead to an increase in blood sugar levels.
No, Dapagliflozin + Metformin + Vildagliptin is not a steroid. It is a combination of three active ingredients where Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, Metformin is a biguanide and Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
This medication combination is not known to affect sleep, but individual reactions can vary. If you experience sleep disturbances after starting the medication, consult your doctor.
This combination of medicine is not known to affect fertility. If you have concerns about fertility, it is advisable to discuss them with your doctor before beginning any new medication.
It is advised to take Dapagliflozin + Metformin + Vildagliptin as prescribed by your doctor. It is important to take this medication exactly as prescribed and keep all of your scheduled medical appointments for monitoring.
The time for this medication to show its effect may vary for each individual. Your doctor should provide you with information on what to expect.
Dapagliflozin + Metformin + Vildagliptin in other salts
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.14
Our Payment Partners